beta-aminoisobutyric acid (INSERM)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namebeta-aminoisobutyric acid (INSERM)
Drug Alias Namebeta-aminoisobutyric acidBAIBA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeptin modulatorsLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm TransfertInserm
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A